The New York State Department of Labor (“DOL”) recently issued proposed statewide regulations that would require employers to pay employees “call-in pay” when employers use “on call” scheduling or change employees’ work shifts on short notice. This is not the DOL’s first foray into this area – in November 2017, the DOL released similar proposed regulations but ultimately declined to adopt them. The DOL’s new set of proposed regulations would apply to the vast majority of employers operating in New York, but are of particular interest to New York City retail employers, who regularly use “on call” scheduling, and who are already subject to the New York City Fair Workweek laws.
Many of you will now be aware of the introduction of the new EU General Data Protection Regulation (‘GDPR’) on 25 May 2018 which applies to all business and organisations which hold data in relation to private individuals. The new rules have raised an interesting query – do solicitors and other professional advisers holding wills on behalf of their clients have an obligation to send beneficiaries named in a will a ‘privacy notice’ informing them that the adviser is holding information about them? Do they need to tell them that they are in fact beneficiaries?
The Ministry of Healthcare of the Russian Federation (“Minzdrav”) has prepared Draft law1 on improvement of the medical drug circulation legislation with regard to the Treaty on unified principles and rules of medical drugs circulation within the Eurasian Economic Union (“EEU”) dated 03.11.2016 No. 78.
The Hon’ble Supreme Court in its recent judgment pronounced on January 7, 2019 in the case of Birla Institute of Technology vs. State of Jharkhand [Civil Appeal No. 2530 of 2012] (“BIT Case”), has endorsed its earlier view taken in the case of Ahmadabad Pvt. Primary Teachers Association vs. Administrative Officer and Others [(2004) 1 SCC 755] (“APPTA Case”) that teachers are not employees for the purposes of Payment of Gratuity Act, 1972 (“PG Act”).
Glasgow solicitors Miller Samuel Hill Brown LLP, “MSHB”, have appointed Marie Macdonald as their new Chairman, succeeding founding Partner, Michael Samuel, who continues as a Consultant with the firm. She becomes the first woman to Chair MSHB, one of Scotland’s longest-established legal practices.
According to a report by West Monroe Partners, Approximately 40% of companies engaged in corporate transactions reported finding a cybersecurity issue during post-acquisition integration of the target company. While companies routinely conduct robust transactional due diligence to manage legal risk, many fail to adequately conduct cybersecurity due diligence. As a consequence, many companies and investors are leaving themselves vulnerable to potentially severe latent cyber risks.
Epstein Becker Green Maintains Its ISO 27001 Certification for 2nd Year, the Highest Accreditation for Information Protection and Security
Epstein Becker Green (EBG) is pleased to announce that, for the second year, it has attained ISO 27001 certification in Information Security Management.
Has the European Union’s latest data privacy regulation, the General Data Protection Regulation (GDPR), come to the United States? All U.S. businesses that ignored the GDPR, or made a determination that the GDPR did not apply to their operations, should now take special note of the requirements imposed by the California Consumer Privacy Act of 2018.
Lewis Rice is proud to announce that Kirk A. Damman was named in Small Business Monthly‘s (SBM‘s) Best Patent Attorneys in St. Louis. Kirk has been included in this list every year since 2016. The honorees are selected based on insights and feedback from SBM’s readers. SBM acts as a resource to the St. Louis business community to understand and connect with the best service providers in the area. St. Louis SBM is a locally owned business publication, bringing business tips, strategies, and analysis to top executives of 17,000 businesses in the St. Louis metropolitan area.
On December 18, 2018 the Food and Drug Administration (“FDA”) finalized guidance on its existing Breakthrough Device Program and announced plans for advancement of the Safer Technologies Program (“STeP”). In the announcement, FDA Commissioner Scott Gottlieb emphasized the FDA’s efforts to promote innovation in medical devices that advance patient safety. This new medical device guidance could signal a year of opportunity for innovative medical device manufacturers that seek to advance patient safety.